Recent research highlights that severe COVID-19 infections can trigger inflammation in the brainstem—often referred to as the brain's "control center"—which is associated with lasting symptoms affecting both physical and mental health. Using advanced 7-Tesla (7T) MRI scanners, scientists at the Universities of Cambridge and Oxford studied patients hospitalized with severe COVID-19 early in the pandemic. They discovered that inflammation in the brainstem was linked to persistent symptoms such as breathlessness, fatigue, anxiety, and depression, commonly experienced by long-COVID sufferers. This inflammation appears to affect key areas of the brainstem, including the medulla oblongata, pons, and midbrain, which are crucial in managing functions like breathing, heart rate, and mood regulation.
The study suggests that the neuroinflammatory response may result from the body's immune reaction to COVID-19 rather than the virus directly invading brain cells. Prior research had shown similar post-infection immune responses, but the current study provides new insight into the specific brain regions involved, thanks to the high-resolution capabilities of 7T MRI. These findings could significantly advance understanding of long-COVID symptoms and other inflammatory brain conditions, such as multiple sclerosis (MS) and dementia, by offering a clearer picture of how infection-related immune responses can impact brain function long after the initial infection subsides.
Moreover, patients in the study who experienced the strongest immune responses displayed higher levels of anxiety and depression, indicating that neuroinflammation in the brainstem may contribute not only to physical symptoms but also to mental health challenges. This study paves the way for new approaches to diagnosing and treating long-COVID, potentially offering insights into therapies that might mitigate these enduring effects on brain health.
This study was funded by the National Institute for Health Research (NIHR) Oxford and Cambridge Biomedical Research Centres and is an essential addition to our growing understanding of COVID-19's impact on the brain, with broader implications for managing post-viral syndromes and neurological health (Cambridge University, NIHR, Neuroscience News)
No comments:
Post a Comment